Clinical trial
TranExamic Atomized for Pediatric Post-Operative Tonsillectomy Hemorrhage (TEAPOT): A Multi-center Feasibility Study
NCT07565753 is registered in ClinicalTrials.gov with The University of Texas Health Science Center at San Antonio as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TranExamic Atomized for Pediatric Post-Operative Tonsillectomy Hemorrhage (TEAPOT): A Multi-center Feasibility Study
- Lead sponsor
- The University of Texas Health Science Center at San Antonio
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- July 14, 2026
- Completion date
- September 30, 2028
- Enrollment
- 30 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
hemorrhage, surgical, tonsillar bleeding